Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference5 articles.
1. Jansen, B. et al. Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356, 1728–1733 (2000).
2. Clayman, G. L. et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16, 2221–2232 (1998).
3. Swisher, S. G. et al. Induction of pro-apoptotic mediators and tumor regression following intratumoral delivery of adenoviral p53 (RPR/INGN201) and radiation therapy in patients with non-small-cell lung cancer. Proc. Am. Soc. Clin. Oncol. 20, A1024 (2001).
4. Buller, R. E. et al. Multi-dose intraperitoneal (IP) RAD/p53 (SCH58500) gene replacement combined with chemotherapy in heavily pretreated recurrent ovarian cancer is associated with prolonged survival. Proc. Am. Soc. Clin. Oncol. 20, A1047 (2001).
5. Khuri, F. R. et al. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med. 6, 879–885 (2000).
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献